Barclays »

Soleno Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Soleno Therapeutics (SLNO) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Soleno Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Soleno Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Soleno Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2025-09-30 $17M 249k 67.60
2025-06-30 $12M 138k 83.78
2025-03-31 $13M 183k 71.44
2024-12-31 $5.7M 127k 44.95
2024-09-30 $2.7M 53k 50.47
2024-06-30 $861k 21k 40.85
2024-03-31 $882k 21k 42.78
2023-12-31 $858k 21k 40.27